The recent clinical data indicate that the initial and the early stages of chronic renal failure (CRF) may lead to increased incidence of cardiovascular complications and increased extent of coronary artery disease (CAD). This retrospective study was aimed to determine the effects of coexisting diabetes mellitus type 2 (DM-2) and the extent of atherosclerosis in coronary vessels in patients with mildly reduced kidney function (glomerular filtration rate GFR = 89 -60 ml/min) and moderately reduced kidney function (GFR = 59 -30 ml/min). The study patients included 53 subjects with creatinine concentration above 120 μmol/l as a cut-off level for the initial stage and compensated CRF. The distributions of coronary artery stenosis were also analysed with respect to DM-2 coexistence and levels of haemoglobin glikolised (HbA1c). The odds ratio of pathological changes in coronary arteries in patients with GFR = 44-30 ml/min, with respect to the number of affected vessels -only one, more than one or more than two -were 7.22, 4.90 and 3.55, respectively. In CRF patients with GFR = 60-89 ml/min the odds ratio of one, more than one and more than two vessels with stenosis and CAD was 1.93, 1.70 and 1.53, respectively. DM-2 was not related to the risk of significant coronary artery stenosis and did not enhance the pre-existing changes in the study setting. Our results demonstrate that the initial and the early stages of CRF were significant risk factors for coronary stenoses and for enhancing the pre-existing changes.
Introduction
Patients with CRF experience increased incidence of cardiovascular diseases and sudden cardiovascular incidents with eventual fatal outcomes [1, 2] . The risk of death due to cardiovascular sudden incident in CRF patients is increasing in parallel with the stage of renal failure reaching 40-50% of all deaths in patients on maintenance hemodialysis (HD) [3, 4] . Nearly three quarters of HD patients demonstrated various cardiovascular disorders including left ventricular hypertrophy, chronic heart failure, CAD, and arrhythmia [5] . The increased incidence of cardiovascular disease is related with the enhanced impact and incidence of risk factors [6] . These risk factors may be commonplace -such as age, male gender, arterial hypertension, lipid disorders, diabetes mellitus, cigarette smoking or menopause -as well as specific for chronic renal failure such as anaemia, parathyroid disorders, excess hydration, dyselectrolytemia, albuminuria, hiperhomocyteinemia, malnutrition, proinflammatory and proagrregatory factors, arterio-venous fistula or inadequate dialysis [2, 6, 7] . Atherosclerosis is more common and more severe in uremic patients than in the general population at a remarkably early stage of chronic kidney disease. The accelerated process of premature coronary atherosclerosis is found in young adults, in whom chronic renal failure started during childhood. Biochemical risk factors include increased oxidative stress, inflammation, increased serum lipid peroxidation products such as maloniandialdehyde in parallel with the decrease of glutathione peroxidase, increased advanced glycation and products (AGEs), increased advanced oxidation protein products (AOPPs) and advanced lipoxidation end products (ALEs). Reactive carbonyl compounds (RCOs), referred to as "carbonyl stress" parameters, lead to the increased levels of AGEs and ALEs, which are all readily deposited in the coronary artery endothelium proportionally to the decreased glomerular filtration rate in addition to the inhibition of nitric oxide synthase activity by accumulated asymmetric dimethylarginine (ADMA). An additional role has been attributed to hyperphosphatemia-induced severe calcification within atherosclerosis plaques in uraemia. Blood vessel smooth muscle cells have been demonstrated to undergo the phenotype transformation into osteoblast-like cells, in the presence of increased phosphate and particularly due to exposure to AOPPs and AGEs that all combined attract macrophages and monocytes capable of neointima infiltration. Therefore, besides conventional atherosclerosis risk factors that were previously stated, AGEs, AOPPs, ADMA, ALEs, phosphates and homocysteine are included among non-conventional coronary atherosclerosis risk factors [8] . Furthermore, the recent clinical data indicate that the initial and the early stages of CRF may bring about the increased incidence of cardiovascular complications [9, 10] . Therefore, this study was aimed at assessing the extent of atherosclerosis in coronary vessels in patients with initial (GFR = 89-60 ml/min) and early (GFR = 59-30 ml/min) stages of chronic renal failure and at determining the effect of coexisting DM-2.
Material and Methods

Study subjects
The retrospective analysis included 437 patients admitted at the Department of Invasive Cardiology and Cardiodiabetology at the Clinical University Hospital No. 2 in Lodz, who all underwent coronarography. The study patients included 53 subjects with creatinine concentration above 120 μmol/l as a cut off level for the initial stage and compensated CRF. The characteristics of each study group are presented in Table 1 . In these patients GFR was calculated based on the CockroftGault equation: GFR = (140-age) x body mass (kg) x constant (1 -for males, 0.85 -in females) / serum creatinine x 72. GFR levels differentiated three groups of patients: A -GFR = 60-89 ml/min, B -GFR = 45-59 ml/min, and C -GFR = 44-30 ml/min. In each group, patients were further differentiated into those with (DM+) or without (DM−) diabetes mellitus type 2 and into those with adequate or unsatisfactory glycemia control: HbA1c ≤ 6.1% or HbA1c > 6.1%, respectively. The control group included patients with serum creatinine concentration below 120 µmol/l and with GFR higher than 89 ml/ min. The results of coronarography further classified the study subjects into five subgroups: patients without changes in coronary arteries, and patients with changes in two, three or four coronary vessels. The distributions of coronary artery stenoses were also analysed with respect to DM-2 coexistence and the levels of HbA1c.
Angiography procedure
After admission, the study patients were qualified for urgent coronarography with thigh or radial artery access (modified Sones' method), using a Shimadzu angiograph with Digitex 2400 system for simultaneous coronary angioplasty. Non-ionic contrast was used (iomeprol -iomeron 350 Bracco ALTANA Pharma Gmbh, Germany). Based on quantitative coronary angiography (QCA), patients were classified into groups with different stages of coronary atherosclerosis. The evaluation included relevant coronary stenosis exceeding 50% vessel diameter in the LAD, Cx and RCA (left anterior descending artery, circumflex artery, right coronary artery; respectively). The changes in the left coronary artery trunk were not analysed. The classification of atherosclerotic plaques was based on the American Heart Association guidelines with respect to angiography images of artery narrowing, predicted efficiency of standard angioplasty, and the probability of complications related to the procedure. 
Biochemical tests
The blood samples were drawn from the antecubital vein on a fasting basis, upon admission. HbA1c concentration was assayed with low-pressure ion exchange chromatography (Drew Scientific Limited, Drew DS 5 Pink 300, Test Reagent Kit-Fast HbA1c Assay). The normal range of HbA1c was ≤ 6.1%. Patients without prior DM-2 diagnosis were divided with respect to Hb1Ac levels: Hb1Ac > 6.1% and Hb1Ac ≤ 6.1%. In patients with HbA1c > 6.1%, oral glucose tolerance test (OGTT) was performed according to WHO 1999 recommendations one month after admission. The diagnostic DM-2 criteria were based on Polish Diabetes Society guidelines 2006. Normal fasting serum glucose level was < 100 mg/dl (5,6 mmol/l), and after two hours of OGTT test it was < 140 mg/dl (7.8 mmol/l). DM-2 was diagnosed by glucose levels ≥ 200 mg/dl (11,1 mmol/l) after two hours. Impaired glucose tolerance (IGT) was defined by levels ≥ 140 mg/dl (7,8 mmol/l) and < 200 mg/dl (11,1 mmol/l) two hours after OGTT. Impaired Fasting Glucose (IFG) was defined as fasting glucose ≥ 110 mg/dl (5,6 mmol/l) but < 126 mg/dl (7,0 mmol/l). The biochemical assays were performed at the local department of laboratory diagnostics at the university hospital.
Statistical analysis
The patients involved in our study were divided into two groups: (1) with no pathological changes; and (2) with one or more pathologically changed coronary arteries. The risk for appearance of pathological changes in the coronary arteries of patients with diabetes and/or various types of kidney insufficiency was assessed based on the odds ratios. In order to assess the significance of DM-2 and CRF as risk factors for the progression of pathological changes in coronary arteries, the data were compared in two ways: (1) patients with 0 and 1 changed arteries versus patients with more than 1 pathologically changed coronary artery; and (2) patients with 2 or less changed arteries versus patients with more than 2 pathologically changed coronary arteries. The analysis of patients allowed us to assess the odds for increasing the number of pathologically changed coronary arteries in patients who already present such changes. A p-value of 0.05 or less was considered significant.
Results
The results of this patient cohort analysis demonstrated that only CRF was a significant risk factor for the development of coronary artery changes as well as a risk factor for enhancing the pre-existing changes (Table 2) . In CRF patients with GFR = 60-89 ml/min (group A), the odds ratios of coronary stenoses in one, more than one, or more than two vessels were 1.93, 1.70 and 1.53, respectively ( Table 5 ). The odds ratios of pathological changes in coronary arteries with respect to one, more than one, or two affected vessels were 3.74, 2.89 and 2.33 respectively in patients with GFR = 59-45 ml/min (group B) ( Table 5 ). In patients with GFR = 44-30 ml/min (group C), the odds ratios of coronary stenoses in one, more than one, or more than two vessels were 7.22, 4.90 and 3.55, respectively (Table 5 ). DM-2 was not related to any significant risk of coronary artery stenosis and did not enhance the pre-existing changes in the study setting (Table 3 and Table 4 ).
Discussion
Patients with CRF were found to face increased incidence of cardiovascular diseases and increased cardiovascular-related mortality rates [2, 3, 12] . The progress of CRF is related with increased incidence of cardiovascular complications and the odds of cardiovascular disease-related fatal outcomes are as high as 40-50% in hemodialyzed patients [3, 4] . The decreased GFR below 75 ml/min is associated with increased risk of cardiovascular incidents in the course of CRF [9, 10, 13] . The increased risk of cardiovascular incidence was demonstrated at decreased GFR below 75 ml/ min, whereas it was evident at GFR below 60 ml/min [11] . Furthermore, GFR decrease of 10 ml/min was associated with 10% increase of sudden cardiovascular incident [11] .
The current study was designed to investigate the incidence and the extent of coronary artery stenosis in patients with initial stages of CRF. Our data indicate that the spread of coronary stenosis is directly proportional to the extent of CRF. The odds ratio of coronary stenosis is 1.93 in patients with GFR in the range 60-89 ml/min, it was as high as 3.74 at GFR = 45-60 ml/min, and it was 7.22 at GFR = 44-30 ml/min, compared with controls. These data cannot be compared with other results, since there are no studies available elaborating on the incidence and extent of coronary stenosis in patients with initial stages of CRF. The existing clinical research demonstrated increased incidence of cardiovascular events and increased cumulative odds of fatal outcome up to 14% at GFR = 60-74 ml/min, 38% at GFR = 45-59 ml/min, and 70% at GFR < 45 ml/min [11] . Similar observations indicated 20% and 80% increases of cumulative odds of cardiovascular-related death at GFR = 45-59 ml/min and 30-44 ml/min, respectively [14, 15] . Further in our study, the extent of coronary stenosis was also directly proportional to the degree of CRF. The index of coronary stenosis in more than one vessel was 1.7 at GFR = 68-89 ml/min, 2.89 at GFR = 45-59 ml/ min and 4.9 at GFR = 44-30 ml/min. In the case of three vessel CAD, it was 1.53, 2.33 and 3.55, respectively. However, no studies are available as a direct reference to these data and to best to our knowledge, this study is the first attempt to assess the effect of CRF on the extent of CAD in coronarography patients [16] [17] [18] [19] [20] .
The patients with initial stages of CRF in our study were further divided into groups based on the existence of DM-2 and on serum HbA1c levels. These groups could not have been subject to statistical analysis due to their inadequate size. The effect of DM-2 on the incidence and extent of coronary stenosis may be reevaluated in future studies specifically designed to test this hypothesis [16] [17] [18] [19] [20] .
These results demonstrate that initial stages of CRF is associated with significant increase of coronary artery stenosis, implicating clinical correlation between minor impairment of renal function and increased risk of cardiovascular-related death in these cohorts of patients.
